Potent cross-reactive antibodies following Omicron breakthrough in vaccinees-Reference-Cited by-同舟云学术

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

Published:2022-06 Issue:12 Volume:185 Page:2116-2131.e18
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Nutalai Rungtiwa,Zhou Daming,Tuekprakhon Aekkachai,Ginn Helen M.,Supasa Piyada,Liu Chang,Huo Jiandong,Mentzer Alexander J.,Duyvesteyn Helen M.E.,Dijokaite-Guraliuc Aiste,Skelly Donal,Ritter Thomas G.,Amini Ali,Bibi Sagida,Adele Sandra,Johnson Sile Ann,Constantinides Bede,Webster Hermione,Temperton Nigel,Klenerman Paul,Barnes Eleanor,Dunachie Susanna J.,Crook Derrick,Pollard Andrew J.,Lambe Teresa,Goulder Philip,Paterson Neil G.,Williams Mark A.,Hall David R.,Mongkolsapaya Juthathip,Fry Elizabeth E.,Dejnirattisai Wanwisa,Ren Jingshan,Stuart David I.^ORCID,Screaton Gavin R.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference54 articles.

1. Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants;Andreano;Nature,2021

2. A time- and cost-efficient system for high-level protein production in mammalian cells;Aricescu;Acta Crystallogr D Biol Crystallogr,2006

3. Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia;Caly;Med. J. Aust.,2020

4. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization;Cele;Nature,2021

5. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with covid-19;Chen;N. Engl. J. Med.,2021

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preventing future zoonosis: SARS-CoV-2 mutations enhance human–animal cross-transmission;Computers in Biology and Medicine;2024-11

2. AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance;Viruses;2024-09-13

3. Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants;npj Vaccines;2024-09-09

4. An update on the anti-spike monoclonal antibody pipeline for SARS-CoV-2;Clinical Microbiology and Infection;2024-08

5. Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike;Structure;2024-08